Burning Rock Biotech (BNR) Invested Capital (2019 - 2026)

Burning Rock Biotech's Invested Capital history runs 6 years deep, the most recent figure standing at $29000.0 for Q1 2026.

• In Q1 2026, Invested Capital changed N/A year-over-year to $29000.0; the TTM figure through Mar 2026 stood at $85198.5 (up 9148121441232508.0% YoY), while the FY2025 annual figure was $28198.5, changed N/A from the prior year.
• Invested Capital for Q1 2026 stood at $29000.0, up from $28198.5 in the prior quarter.
• The five-year high for Invested Capital was $354000.0 in Q2 2022, with the low at $28000.0 in Q2 2025.
• The 3-year median for Invested Capital is $28599.3 (2026), against an average of $109799.6.
• Peak annual rise in Invested Capital reached 92.41% in 2022, while the deepest fall reached 92.41% in 2022.
• Burning Rock Biotech's Invested Capital stood at $354000.0 in 2022, then plunged by 92.03% to $28198.5 in 2025, then advanced by 2.84% to $29000.0 in 2026.
• Business Quant data shows BNR's Invested Capital at $29000.0 in Q1 2026, $28198.5 in Q4 2025, and $28000.0 in Q2 2025.